Stay updated with breaking news from Month Gap. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
We are pleased to present our annual End of Year Plan Sponsor “To Do” Lists. This year, we present our “To Do” Lists in four separate Employee Benefits Updates. This Part 1 covers...
A high level panel of US medical experts voted unanimously Friday to recommend authorizing a second shot of the Johnson & Johnson Covid vaccine.
California, N.Y. to Open New Stadium Vaccine Sites: Virus Update Bloomberg 2/3/2021 Bloomberg News © Bloomberg People wearing protective masks wait in line to receive a dose of the Moderna Covid-19 vaccine at a walk up vaccination site in San Francisco, California, U.S., on Wednesday, Feb. 3, 2021. (Bloomberg) -- AstraZeneca Plc and the University of Oxford have started looking at how to re-engineer their coronavirus vaccine to defeat new mutations, saying a tweaked injection could be ready by autumn. GlaxoSmithKline Plc agreed to work with CureVac NV to help boost produc...
California, N.Y. to Open New Stadium Vaccine Sites: Virus Update Bloomberg 3/02/2021 Bloomberg News © Bloomberg People wearing protective masks wait in line to receive a dose of the Moderna Covid-19 vaccine at a walk up vaccination site in San Francisco, California, U.S., on Wednesday, Feb. 3, 2021. (Bloomberg) -- AstraZeneca Plc and the University of Oxford have started looking at how to re-engineer their coronavirus vaccine to defeat new mutations, saying a tweaked injection could be ready by autumn. GlaxoSmithKline Plc agreed to work with CureVac NV to help boost produ...
California, N.Y. to Open New Stadium Vaccine Sites: Virus Update Bloomberg 3/02/2021 Bloomberg News © Bloomberg People wearing protective masks wait in line to receive a dose of the Moderna Covid-19 vaccine at a walk up vaccination site in San Francisco, California, U.S., on Wednesday, Feb. 3, 2021. (Bloomberg) -- AstraZeneca Plc and the University of Oxford have started looking at how to re-engineer their coronavirus vaccine to defeat new mutations, saying a tweaked injection could be ready by autumn. GlaxoSmithKline Plc agreed to work with CureVac NV to help boost produ...